| Yousuf N Ahmad, MD | |
|
1101 Nott St, Schenectady, NY 12308-2425 | |
| (518) 243-4000 | |
| Not Available |
| Full Name | Yousuf N Ahmad |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Child & Adolescent Psychiatry |
| Location | 1101 Nott St, Schenectady, New York |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316143613 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 237723 (New York) | Primary |
| 2084P0804X | Psychiatry & Neurology - Child & Adolescent Psychiatry | 237723 (New York) | Primary |
| Entity Name | Ellis Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487644993 PECOS PAC ID: 5890607410 Enrollment ID: O20031103000406 |
News Archive
Regeneron and Sanofi today announced that the European Medicines Agency has accepted for review the Marketing Authorization Application for Praluent (alirocumab). Alirocumab is an investigational monoclonal antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type 9) that is intended for the treatment of patients with hypercholesterolemia.
A new Ebola test that uses magnetic nanoparticles could help curb the spread of the disease in western Africa. Research published in Biosensors and Bioelectronics shows that the new test is 100 times more sensitive than the current test, and easier to use. Because of this, the new test makes it easier and cheaper to diagnose cases, enabling healthcare workers to isolate patients and prevent the spread of Ebola.
One of the nation's pre-eminent genetic researchers, Eric Hoffman, PhD, of Children's Research Institute at Children's National Medical Center, predicts that in relatively short order, medicine's next innovation-individualized molecular therapies-will have the unprecedented ability to treat muscular dystrophies, and other disorders.
Boehringer Ingelheim today announced new data from large scale, Phase III studies showing that once-daily tiotropium delivered via the Respimat® inhaler was effective and well tolerated in patients across asthma severities.
› Verified 3 days ago
| Entity Name | Fw Of Saratoga Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386640084 PECOS PAC ID: 6305747049 Enrollment ID: O20040116000089 |
News Archive
Regeneron and Sanofi today announced that the European Medicines Agency has accepted for review the Marketing Authorization Application for Praluent (alirocumab). Alirocumab is an investigational monoclonal antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type 9) that is intended for the treatment of patients with hypercholesterolemia.
A new Ebola test that uses magnetic nanoparticles could help curb the spread of the disease in western Africa. Research published in Biosensors and Bioelectronics shows that the new test is 100 times more sensitive than the current test, and easier to use. Because of this, the new test makes it easier and cheaper to diagnose cases, enabling healthcare workers to isolate patients and prevent the spread of Ebola.
One of the nation's pre-eminent genetic researchers, Eric Hoffman, PhD, of Children's Research Institute at Children's National Medical Center, predicts that in relatively short order, medicine's next innovation-individualized molecular therapies-will have the unprecedented ability to treat muscular dystrophies, and other disorders.
Boehringer Ingelheim today announced new data from large scale, Phase III studies showing that once-daily tiotropium delivered via the Respimat® inhaler was effective and well tolerated in patients across asthma severities.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Yousuf N Ahmad, MD 1462 Erie Blvd, Suite 2, Schenectady, NY 12305-1026 Ph: (518) 243-1500 | Yousuf N Ahmad, MD 1101 Nott St, Schenectady, NY 12308-2425 Ph: (518) 243-4000 |
News Archive
Regeneron and Sanofi today announced that the European Medicines Agency has accepted for review the Marketing Authorization Application for Praluent (alirocumab). Alirocumab is an investigational monoclonal antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type 9) that is intended for the treatment of patients with hypercholesterolemia.
A new Ebola test that uses magnetic nanoparticles could help curb the spread of the disease in western Africa. Research published in Biosensors and Bioelectronics shows that the new test is 100 times more sensitive than the current test, and easier to use. Because of this, the new test makes it easier and cheaper to diagnose cases, enabling healthcare workers to isolate patients and prevent the spread of Ebola.
One of the nation's pre-eminent genetic researchers, Eric Hoffman, PhD, of Children's Research Institute at Children's National Medical Center, predicts that in relatively short order, medicine's next innovation-individualized molecular therapies-will have the unprecedented ability to treat muscular dystrophies, and other disorders.
Boehringer Ingelheim today announced new data from large scale, Phase III studies showing that once-daily tiotropium delivered via the Respimat® inhaler was effective and well tolerated in patients across asthma severities.
› Verified 3 days ago
Dr. Christopher Scott Burky, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 31 Lafayette St, Schenectady, NY 12305 Phone: 518-381-8911 Fax: 518-377-4292 | |
Dr. Arun Kumar Dhingra, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1101 Nott St, Dept. Of Psychiatry, Schenectady, NY 12308 Phone: 518-243-4154 Fax: 518-243-4170 | |
Bharat B Langer, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1044 State St, Schenectady, NY 12307 Phone: 518-370-1441 Fax: 518-395-9431 | |
Peeyush Mittal, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1044 State St, Schenectady, NY 12307 Phone: 518-370-1441 Fax: 518-395-9431 | |
Dr. Naseer A Chowdhrey, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2125 River Rd, Suite 303, Schenectady, NY 12309 Phone: 518-381-1800 Fax: 518-381-1801 | |
Beatrice M Kovasznay, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1101 Nott St, Dept Of Psychiatry, Schenectady, NY 12308 Phone: 518-243-4162 |